Implanted pump offers new hope for those battling unpredictable blood sugar

NCT ID NCT06739811

Recruiting now Disease control Sponsor: Medtronic Diabetes Source: ClinicalTrials.gov ↗

Summary

This study is testing a new insulin pump that is surgically implanted in the body for adults with Type 1 diabetes whose blood sugar is very hard to manage with current treatments. The goal is to see if this implanted system can deliver insulin more accurately and help prevent dangerous high and low blood sugar episodes. About 40 participants will have the pump placed and be followed for at least 6 months to see how well it works.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHU Dijon Bourgogne
RECRUITING

Dijon, 21100, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Centre Hospitalier Universitaire De Montpellier
RECRUITING

Montpellier, France, 34295, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hôpital Européen Marseille
RECRUITING

Marseille, 13003, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hôpital Lariboisière & Fernand-Widal
ACTIVE_NOT_RECRUITING

Paris, France
Hôpitaux Universitaires de Strasbourg - Nouvel Hôpital Civil
RECRUITING

Strasbourg, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Isala Zwolle
RECRUITING

Zwolle, Netherlands, 8025 AB, Netherlands

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

TYPE I DIABETES